Amar Remedies Ltd vs MARICO LIMITED

A side-by-side comparison of Amar Remedies Ltd (AMAR) and MARICO LIMITED (MARICO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, MARICO LIMITED leads AMAR vs MARICO on 7 of 14 metrics (3 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability03
  • Growth· not comparable
  • Size & financial health13

Valuation

AMAR takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
61.75
0.00
P/B ratio
19.14
0.00%
Dividend yield
0.48%
₹17.29
EPS
₹13.57

Profitability

MARICO takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.60%
Return on equity
43.00%
19.00%
Return on capital
47.00%
17.00%
EBITDA margin even
17.00%
6.68%
Net margin
13.32%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y) even
11.71%
Profit CAGR (3Y) even
11.10%

Size & financial health

MARICO takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹1.09L Cr
₹674 Cr
Revenue
₹13,611 Cr
₹45 Cr
Net profit
₹1,813 Cr
0.00
Debt / equity
0.03
Amar Remedies Ltd
  • + ["Stock is trading at 0.06 times its book value", "Company has delivered good profit growth of 23.6% CAGR over last 5 years"]
MARICO LIMITED
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 40.9%", "Company has been maintaining a healthy dividend payout of 65.1%"]
  • ["Stock is trading at 25.6 times its book value", "The company has delivered a poor sales growth of 11.1% over past five years."]
Amar Remedies Ltd full analysis MARICO LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.